Literature DB >> 17900975

Correlations of nerve conduction measures in axonal and demyelinating polyneuropathies.

Hatice Tankisi1, Kirsten Pugdahl, Birger Johnsen, Anders Fuglsang-Frederiksen.   

Abstract

OBJECTIVE: In a considerable proportion of patients with polyneuropathy the electrophysiological distinction between primarily demyelinating or axonal pathology is not straightforward. This study aimed at determining whether the relation between the sensory nerve action potential (SNAP)/compound muscle action potential (CMAP) amplitude and conduction velocity (CV) or distal motor latency (DML) in demyelinating versus axonal polyneuropathy could be helpful in distinguishing these two pathophysiologies.
METHODS: The relation between amplitude reduction and conduction slowing was performed using regression analysis in nerve conduction studies from 53 axonal polyneuropathies and 45 demyelinating polyneuropathies. Sensory nerve conduction studies were performed using the near-nerve needle technique. Finally, needle EMG findings in 31 muscles in axonal and in 22 muscles in demyelinating polyneuropathies were compared.
RESULTS: A linear correlation between action potential amplitude and CV was seen in the majority of nerves in both axonal and demyelinating polyneuropathies. Further, an inverse linear correlation between CMAP amplitude and DML was found in most of the nerves in axonal polyneuropathies. The incidence and degree of abnormality, including decrease in action potential amplitude, was more pronounced in demyelinating than in axonal polyneuropathies, while there was no difference in EMG findings.
CONCLUSIONS: Amplitude reduction and conduction slowing were correlated in axonal as well as demyelinating polyneuropathies, and a significant reduction in SNAP and CMAP amplitudes was found in demyelinating as well as axonal polyneuropathies. The correlation in axonal polyneuropathies can be attributed to a concomitant or selective loss of large, fast conducting fibers, whereas the correlation in demyelinating polyneuropathies may be explained by temporal dispersion or secondary axonal degeneration. SIGNIFICANCE: At present, relation between amplitude reduction and conduction slowing does not seem to be useful in revealing the primary pathophysiology of a polyneuropathy. Decrease in CV, increase in DML, increase in F-wave latency, conduction block and temporal dispersion should mainly be considered. Decrease in amplitude must be interpreted with caution.

Entities:  

Mesh:

Year:  2007        PMID: 17900975     DOI: 10.1016/j.clinph.2007.07.027

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  15 in total

1.  New findings in the ataxia of Charlevoix-Saguenay.

Authors:  José Gazulla; Isabel Benavente; Ana Carmen Vela; Miguel Angel Marín; Luis Emilio Pablo; Alessandra Tessa; María Rosario Barrena; Filippo Maria Santorelli; Claudia Nesti; Pedro Modrego; María Tintoré; José Berciano
Journal:  J Neurol       Date:  2011-10-13       Impact factor: 4.849

2.  Reducing monocarboxylate transporter MCT1 worsens experimental diabetic peripheral neuropathy.

Authors:  Mithilesh Kumar Jha; Xanthe H Ament; Fang Yang; Ying Liu; Michael J Polydefkis; Luc Pellerin; Brett M Morrison
Journal:  Exp Neurol       Date:  2020-07-25       Impact factor: 5.330

3.  Identification of prolonged phrenic nerve conduction time in the ICU: magnetic versus electrical stimulation.

Authors:  Alexandre Demoule; Capucine Morelot-Panzini; Hélène Prodanovic; Christophe Cracco; Julien Mayaux; Alexandre Duguet; Thomas Similowski
Journal:  Intensive Care Med       Date:  2011-10-18       Impact factor: 17.440

Review 4.  Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.

Authors:  José Berciano; Antonio García; Elena Gallardo; Kristien Peeters; Ana L Pelayo-Negro; Silvia Álvarez-Paradelo; José Gazulla; Miriam Martínez-Tames; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2017-03-31       Impact factor: 4.849

5.  Tendon injury produces changes in SSCT and nerve physiology similar to carpal tunnel syndrome in an in vivo rabbit model.

Authors:  Tamami Moriya; Chunfeng Zhao; Stephen S Cha; James D Schmelzer; Phillip A Low; Kai-Nan An; Peter C Amadio
Journal:  Hand (N Y)       Date:  2011-09-10

6.  Is distal motor and/or sensory demyelination a distinctive feature of anti-MAG neuropathy?

Authors:  Pierre Lozeron; Vincent Ribrag; David Adams; Marion Brisset; Marguerite Vignon; Marine Baron; Marion Malphettes; Marie Theaudin; Bertrand Arnulf; Nathalie Kubis
Journal:  J Neurol       Date:  2016-06-17       Impact factor: 4.849

Review 7.  Charcot-Marie-Tooth disease and intracellular traffic.

Authors:  Cecilia Bucci; Oddmund Bakke; Cinzia Progida
Journal:  Prog Neurobiol       Date:  2012-03-22       Impact factor: 11.685

8.  Myopathic changes in patients with long-term fatigue after COVID-19.

Authors:  J Agergaard; S Leth; T H Pedersen; T Harbo; J U Blicher; P Karlsson; L Østergaard; H Andersen; H Tankisi
Journal:  Clin Neurophysiol       Date:  2021-05-07       Impact factor: 3.708

9.  A novel approach for evaluating nerve function in healthy elderly persons: a pilot study.

Authors:  Ken Nishihara; Hisashi Kawai; Naohiko Kanemura; Motohiko Hara; Hideo Naruse; Toshiaki Gomi
Journal:  Med Sci Monit       Date:  2013-04-29

10.  Conduction slowing in diabetic sensorimotor polyneuropathy.

Authors:  Samantha K Dunnigan; Hamid Ebadi; Ari Breiner; Hans D Katzberg; Leif E Lovblom; Bruce A Perkins; Vera Bril
Journal:  Diabetes Care       Date:  2013-09-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.